Sirolimus shows inhibition of tumour growth

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1332, 2002-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of P-glycoprotein in tumour cells

By LeBlanc G.A.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 121-123

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of tumour necrosis factor-alpha (TNF-)

By Tu G.   Cau Q-n.   Zhou F.   Isreal Y.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 23-25

Informa Healthcare

Access to resources Recommend Favorite

Effect of Carboxylesterase Inhibition on the Anti-tumour Effects of Irinotecan

By Morishita Y   Fujii M   Kasakura Y   Takayama T  

The Journal of International Medical Research, Vol. 33, Iss. 1, 2005-01 ,pp. : 84-89

Field House Publishing

Access to resources Recommend Favorite

Methionine aminopeptidase 2 inhibition: antiangiogenesis and tumour therapy

By Bradshaw Ralph A  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 1-6

Informa Healthcare

Access to resources Recommend Favorite

Dasatinib: An Anti-Tumour Agent via Src Inhibition

By  

Current Drug Targets, Vol. 12, Iss. 4, 2011-04 ,pp. : 563-578

Bentham Science Publishers

Access to resources Recommend Favorite